The University of Kansas Cancer Center reposted this
New study: FDA-mandated CAR-T monitoring period could be halved. Read more from Nausheen Ahmed, M.D. at The University of Kansas Cancer Center and colleagues: https://ow.ly/aY2s50SJesU #CART #Lymphoma #ICANS #CARTcells #CRS #DLBCL